Yongli L. Chu

No. 20 East Yuhuangding Road
Yantai, 264000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Corrigendum to "Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development" [Tissue Cell 93 (2025) 102713].

Corrigendum to "Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development" [Tissue Cell 93 (2025) 102713].

Journal: Tissue & cell

Published: March 21, 2026

CT-based variables of perirenal fat are risk factors for assessing pathological T-stage in patients with clear cell renal cell carcinoma.

CT-based variables of perirenal fat are risk factors for assessing pathological T-stage in patients with clear cell renal cell carcinoma.

Journal: Annals of medicine

Published: February 09, 2026

Stem cell-based tactics in the remodeling and treatment of intestinal diseases.

Stem cell-based tactics in the remodeling and treatment of intestinal diseases.

Journal: Stem cell research & therapy

Published: October 14, 2025

Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development.

Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development.

Journal: Tissue & cell

Published: November 18, 2024

Construction of a Single-cell Atlas of Thyroid Cancer

Construction of a Single-cell Atlas of Thyroid Cancer

Journal: Endocrine, metabolic & immune disorders drug targets

Published: September 23, 2024

ACAP1 could serve as a novel prognostic biomarker associated with tumor immunity in clear-cell renal cell carcinoma: A comprehensive analysis by integrating bulk and single-cell sequencing.

ACAP1 could serve as a novel prognostic biomarker associated with tumor immunity in clear-cell renal cell carcinoma: A comprehensive analysis by integrating bulk and single-cell sequencing.

Journal: Asian journal of surgery

Published: March 27, 2024

Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC.

Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC.

Journal: NPJ precision oncology

Published: February 27, 2024

Engineered Extracellular Vesicles Expressing Siglec-10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor-Associated Antigens for Photodynamic Immunotherapy.

Engineered Extracellular Vesicles Expressing Siglec-10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor-Associated Antigens for Photodynamic Immunotherapy.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: September 12, 2023

The pooled analysis evaluates the therapeutic efficacy of desmopressin combined with anticholinergic drugs in the treatment of pediatric nocturnal enuresis.

The pooled analysis evaluates the therapeutic efficacy of desmopressin combined with anticholinergic drugs in the treatment of pediatric nocturnal enuresis.

Journal: Neurourology and urodynamics

Published: August 23, 2023

Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis.

Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis.

Journal: BMC urology

Published: June 20, 2023

The Efficacy of Cyclooxygenase-2 Inhibitors for the Male Treatment of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis.

The Efficacy of Cyclooxygenase-2 Inhibitors for the Male Treatment of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis.

Journal: American journal of men's health

Published: May 30, 2023

Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.

Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.

Journal: Pharmacological research

Published: May 12, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026